의료용 체온계 시장 : 제품 유형, 기술, 최종 사용자, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Medical Thermometer Market is projected to grow by USD 9.93 billion at a CAGR of 16.45% by 2032.

Medical Thermometer Market Introduction

The medical thermometer market is being reshaped by the global need for rapid, reliable, and user-friendly body temperature measurement across hospitals, clinics, pharmacies, schools, workplaces, long-term care facilities, and home-care settings. Temperature remains one of the most widely used vital signs because fever is a common indicator of infection, inflammation, vaccine response, heat illness, and post-operative complications.

Demand is strongest for digital thermometers, infrared forehead thermometers, tympanic thermometers, wearable temperature sensors, and connected devices that integrate with electronic health records or consumer health apps. Adoption is supported by aging populations, higher chronic disease monitoring, greater parental focus on pediatric care, and lessons learned from COVID-19, influenza, RSV, and other seasonal respiratory outbreaks. Regulatory expectations from agencies such as the U.S. FDA, Health Canada, the European Commission, and national medical device authorities continue to prioritize accuracy, labeling, calibration, biocompatibility, electromagnetic compatibility, and risk management for devices used in clinical and consumer environments.

Transformative Shifts in the Medical Thermometer Landscape

The landscape is shifting from mercury-based and basic digital devices toward non-contact, connected, and workflow-integrated temperature monitoring. Mercury thermometers have been restricted or phased down in many jurisdictions because mercury is a persistent environmental and neurotoxic hazard, while digital alternatives offer faster readings and safer disposal profiles.

Healthcare providers are also moving from episodic measurement to continuous or near-continuous monitoring in acute care, elder care, remote patient monitoring, and post-discharge recovery. At the same time, retail pharmacies and e-commerce platforms have increased consumer access to validated home thermometers, making brand trust, clinical accuracy, battery life, sensor durability, sanitation, and clear user instructions key competitive factors.

Supply chains are becoming more diversified after pandemic-era shortages exposed dependency risks in sensors, microcontrollers, displays, packaging, and medical-grade plastics. Manufacturers are prioritizing dual sourcing, regional assembly, automated quality inspection, calibration traceability, and compliance-ready documentation to meet hospital procurement requirements and consumer safety expectations.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is adding cumulative value to medical thermometers by transforming isolated temperature readings into actionable health signals. AI-enabled systems can help detect abnormal temperature trends, filter noise from motion or poor sensor placement, flag deterioration risk, and support triage when integrated with heart rate, respiratory rate, oxygen saturation, sleep, activity, and symptom data.

In clinical environments, AI can improve remote patient monitoring by prioritizing alerts and reducing alarm fatigue. In public health and occupational settings, thermal imaging analytics may help identify elevated skin temperature patterns, although regulators and clinical guidance emphasize that such systems are screening tools and cannot diagnose infection on their own.

The long-term opportunity lies in validated algorithms, transparent model performance, cybersecurity, interoperability, and responsible data governance. Manufacturers that align AI features with FDA software guidance, EU Medical Device Regulation requirements, privacy-by-design principles, post-market surveillance, and real-world clinical evidence will be better positioned than companies that market AI as a feature without measurable accuracy or workflow benefits.

Key Regional Insights for Medical Thermometers

Asia-Pacific is a high-volume growth region due to large populations, expanding middle-class healthcare spending, manufacturing depth in China, Japan, South Korea, and India, and rising use of digital health tools in hospitals and home care. The region benefits from pediatric demand, infectious disease preparedness, urban hospital expansion, and local electronics ecosystems that support cost-efficient sensor production and device assembly.

North America remains a premium market shaped by FDA and Health Canada oversight, strong hospital purchasing power, broad retail pharmacy access, telehealth adoption, and high use of connected home health devices. Europe is driven by stringent product safety expectations under the EU Medical Device Regulation, environmental policies that discourage mercury devices, and mature demand from hospitals, elder care, pharmacies, and primary care networks.

Latin America is gaining momentum as pharmacies, private clinics, and public health programs increase access to digital and infrared thermometers, with Brazil and Mexico anchoring demand through large patient populations and expanding healthcare retail channels. The Middle East shows strong procurement potential through hospital modernization, especially in Gulf markets, while Africa is characterized by essential-care demand, infectious disease surveillance needs, and growing opportunities for durable, affordable, battery-efficient devices suited to decentralized and resource-limited care settings.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is supported by growing healthcare infrastructure, dense urban populations, expanding pharmacy networks, and rising household adoption of digital thermometers, with procurement preferences favoring affordable, reliable, and easy-to-clean products. GCC markets emphasize premium hospital equipment, connected care, imported medical devices, and public health readiness aligned with specialty care expansion and national healthcare transformation programs.

The European Union is one of the most compliance-intensive markets, where MDR conformity, traceability, labeling, clinical evaluation, and environmental considerations influence supplier selection. BRICS countries represent major scale opportunities because China and India combine manufacturing strength with huge domestic demand, while Brazil, Russia, and South Africa add public-sector procurement, private healthcare growth, and demand for cost-effective diagnostic tools.

G7 markets are characterized by high regulatory scrutiny, sophisticated distribution, mature pharmacy channels, and consumer willingness to pay for trusted devices with proven accuracy. NATO members overlap with many high-income healthcare systems where resilience, stockpiling, interoperability, and procurement reliability have become more important after the pandemic, especially for essential diagnostic and monitoring devices used in hospitals, emergency response, and community care.

Key Country Insights for Priority Medical Thermometer Markets

The United States leads premium demand through hospitals, pharmacies, urgent care centers, telehealth-enabled home monitoring, and FDA-regulated product pathways, while Canada emphasizes device safety, bilingual labeling, and reliable distribution across dispersed geographies. Mexico combines growing private healthcare demand with proximity to North American supply chains, and Brazil remains Latin America's largest healthcare market with strong public and private procurement channels for clinics, hospitals, and retail pharmacies.

In Europe, the United Kingdom prioritizes NHS procurement efficiency, clinical usability, and home-care access, Germany favors clinically validated engineering and hospital-grade quality, France supports regulated pharmacy channels and consumer health adoption, Italy and Spain show steady demand from aging populations and primary care networks, and Russia maintains demand across hospital and household use despite supply-chain complexity and import considerations.

In Asia-Pacific, China combines large-scale production with rapidly expanding domestic consumption; India is driven by affordability, pediatric care, and expanding diagnostics access; Japan emphasizes precision, aging-related care, and high consumer quality expectations; Australia supports premium, regulated home-care and clinical demand; and South Korea benefits from advanced electronics, digital health adoption, strong hospital infrastructure, and export-oriented device capabilities.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated accuracy, easy sanitation, rapid read times, durability, and human-centered design for pediatric, geriatric, hospital, public health, and home-care users. Companies should clearly distinguish between core temperature, oral, rectal, axillary, tympanic, temporal, and skin-surface measurements to avoid misleading claims and strengthen clinician and consumer trust.

Manufacturers should invest in connected thermometers that integrate securely with remote patient monitoring platforms, EHR systems, and consumer health applications. Growth strategies should also include regionalized supply chains, verified component sourcing, battery and sensor reliability testing, calibration protocols, cybersecurity controls, and compliance documentation that accelerates regulatory submissions and institutional procurement.

Commercial teams should segment pricing by care setting: premium AI-enabled and connected devices for hospitals, durable infrared models for clinics and pharmacies, and affordable digital thermometers for households, schools, workplaces, and public health programs. Evidence-based marketing, post-market surveillance, transparent cleaning instructions, and clear calibration guidance will be essential for long-term brand credibility.

Research Methodology

This executive summary is grounded in a structured research methodology combining secondary research, primary validation, and analytical triangulation. Secondary sources include public health guidance from organizations such as WHO and CDC, regulatory information from the FDA, Health Canada, and the European Commission, national health agencies, medical device standards, procurement references, patent activity, product documentation, and distribution-channel analysis.

Primary research typically includes interviews with device manufacturers, component suppliers, distributors, hospital procurement specialists, clinicians, pharmacists, biomedical engineers, and digital health stakeholders. Findings are validated through cross-source comparison, regulatory review, market segmentation, and assessment of technology adoption across product types, end users, and geographies.

The methodology emphasizes verified evidence over promotional claims. Market interpretation considers clinical utility, regulatory status, supply-chain resilience, pricing behavior, channel access, usability, sanitation requirements, and the practical limitations of different thermometer technologies in real-world use.

Conclusion

The medical thermometer market is evolving from a basic household necessity into a connected, regulated, and data-enabled segment of modern healthcare. Demand is supported by infection surveillance, pediatric and geriatric care, chronic disease monitoring, telehealth, occupational health, school health programs, and the enduring need for accurate vital sign measurement.

Future winners will combine validated sensor performance, regulatory discipline, affordable access, AI-enabled insight, cybersecurity, and resilient supply chains. Companies that deliver trustworthy readings, clear clinical use cases, intuitive user experience, and seamless integration into care workflows will be best positioned to capture growth across hospitals, pharmacies, home care, and public health systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Medical Thermometer Market, by Product Type

• 7.1. Digital Thermometers
• 7.2. Axillary Digital Thermometers
• 7.3. Rectal Digital Thermometers

8. Medical Thermometer Market, by Technology

• 8.1. Contact
  • 8.1.1. Oral
  • 8.1.2. Rectal
  • 8.1.3. Underarm
• 8.2. Non-Contact
  • 8.2.1. Forehead
  • 8.2.2. Tympanic

9. Medical Thermometer Market, by End User

• 9.1. Clinic
  • 9.1.1. Ambulatory
  • 9.1.2. Outpatient
• 9.2. Home
• 9.3. Hospital
  • 9.3.1. General Ward
  • 9.3.2. ICU

10. Medical Thermometer Market, by Distribution Channel

• 10.1. Offline
  • 10.1.1. Pharmacy Store
  • 10.1.2. Supermarket
• 10.2. Online

11. Medical Thermometer Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Medical Thermometer Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Medical Thermometer Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. 3M Company
• 15.2. A&D Company, Limited
• 15.3. American Diagnostic Corporation
• 15.4. Baxter International Inc.
• 15.5. Berrcom Group
• 15.6. Beurer GmbH
• 15.7. BPL Medical Technologies Pvt. Ltd.
• 15.8. Cardinal Health, Inc.
• 15.9. Easywell Biomedicals, Inc.
• 15.10. Exergen Corporation
• 15.11. Geratherm Medical AG
• 15.12. Hicks Thermometers India Limited
• 15.13. iHealth Labs Inc.
• 15.14. Innovo Medical, Inc.
• 15.15. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
• 15.16. Kaz USA, Inc.
• 15.17. Kinsa Inc.
• 15.18. Mediaid Inc.
• 15.19. Medline Industries, LP
• 15.20. Microlife Corporation
• 15.21. Omron Corporation
• 15.22. Paul Hartmann AG
• 15.23. Procter & Gamble Company
• 15.24. Tecnimed S.r.l.
• 15.25. Terumo Corporation